These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, Teipel SJ, Grothe MJ. Brain; 2018 Jan 01; 141(1):165-176. PubMed ID: 29228203 [Abstract] [Full Text] [Related]
3. Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-β Status in Parkinson's disease-Related Cognitive Decline. Labrador-Espinosa MA, Silva-Rodríguez J, Reina-Castillo MI, Mir P, Grothe MJ. Mov Disord; 2023 Oct 01; 38(10):1871-1880. PubMed ID: 37492892 [Abstract] [Full Text] [Related]
4. Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson's disease. Wilson H, de Natale ER, Politis M. Handb Clin Neurol; 2021 Oct 01; 179():189-205. PubMed ID: 34225962 [Abstract] [Full Text] [Related]
5. Nucleus basalis of Meynert neuronal activity in Parkinson's disease. Lee DJ, Milosevic L, Gramer R, Sasikumar S, Al-Ozzi TM, De Vloo P, Dallapiazza RF, Elias GJB, Cohn M, Kalia SK, Hutchison WD, Fasano A, Lozano AM. J Neurosurg; 2020 Feb 01; 132(2):574-582. PubMed ID: 30797189 [Abstract] [Full Text] [Related]
6. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease. Pereira JB, Hall S, Jalakas M, Grothe MJ, Strandberg O, Stomrud E, Westman E, van Westen D, Hansson O. Neurobiol Dis; 2020 Jun 01; 139():104831. PubMed ID: 32145376 [Abstract] [Full Text] [Related]
7. Free-Water Imaging of the Nucleus Basalis of Meynert in Patients With Idiopathic REM Sleep Behavior Disorder and Parkinson Disease. Zhang D, Zhou L, Lu C, Feng T, Liu J, Wu T. Neurology; 2024 Apr 09; 102(7):e209220. PubMed ID: 38489578 [Abstract] [Full Text] [Related]
8. Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease. Wilson J, Yarnall AJ, Craig CE, Galna B, Lord S, Morris R, Lawson RA, Alcock L, Duncan GW, Khoo TK, O'Brien JT, Burn DJ, Taylor JP, Ray NJ, Rochester L. Mov Disord; 2021 Mar 09; 36(3):611-621. PubMed ID: 33382126 [Abstract] [Full Text] [Related]
11. Multimodal magnetic resonance imaging investigation of basal forebrain damage and cognitive deficits in Parkinson's disease. Gargouri F, Gallea C, Mongin M, Pyatigorskaya N, Valabregue R, Ewenczyk C, Sarazin M, Yahia-Cherif L, Vidailhet M, Lehéricy S. Mov Disord; 2019 Apr 01; 34(4):516-525. PubMed ID: 30536444 [Abstract] [Full Text] [Related]
12. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology. Nazmuddin M, van Dalen JW, Borra RJH, Stormezand GN, van der Horn HJ, van der Zee S, Boertien J, van Laar T. Parkinsonism Relat Disord; 2021 Dec 01; 93():43-49. PubMed ID: 34784526 [Abstract] [Full Text] [Related]
13. Delusions and visual hallucinations in a patient with Parkinson's disease with dementia showing pronounced Lewy body pathology in the nucleus basalis of Meynert. Sakai K, Ikeda T, Ishida C, Komai K, Yamada M. Neuropathology; 2019 Aug 01; 39(4):319-323. PubMed ID: 31243794 [Abstract] [Full Text] [Related]
14. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease. Liu AK, Chang RC, Pearce RK, Gentleman SM. Acta Neuropathol; 2015 Apr 01; 129(4):527-40. PubMed ID: 25633602 [Abstract] [Full Text] [Related]
15. Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment. Rong S, Li Y, Li B, Nie K, Zhang P, Cai T, Mei M, Wang L, Zhang Y. Quant Imaging Med Surg; 2021 Apr 01; 11(4):1554-1566. PubMed ID: 33816191 [Abstract] [Full Text] [Related]